And The UK's First 'Innovation Passport' Goes To... MSD's Rare Disease Drug Belzutifan
Regulator Invites More Applications For New Pathway
The MHRA is losing no time in getting its much heralded “new era” of medicines regulation up and running.
You may also be interested in...
The cancer drug is also to undergo an accelerated assessment by the European Medicines Agency.
News and highlights of applications submitted for US FDA approval, from the Pink Sheet’s FDA Performance Tracker
New partnerships forged between the UK medicines regulator and health technology assessment bodies during COVID-19 have resulted in an improved understanding of the benefits new drugs can bring to the NHS and how to manage their rapid introduction.